CytomX Therapeutics CTMX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$59.14M-242% | -$17.37M-154% | $28.02M— | $47.98M— | $41.6M— | ||
| $9M+15.8% | $6.3M-17.8% | $6.71M-19.5% | $7.32M-3.3% | $7.77M-3.6% | ||
| -$80.09M+1.4% | -$75.59M+12.3% | -$72.25M+18.2% | -$77.43M+9.8% | -$81.23M+11.2% | ||
| —— | —— | —— | $245K-49.6% | $314K-65.4% | ||
| -$283.56M-432% | -$60.18M-160% | -$30.63M— | -$12.46M— | $85.41M— | ||
| $344.93M+4,594% | $110.45M+1,368% | $96.05M+1,641% | $95.8M+172% | $7.35M-75.8% | ||
| -$18.28M— | -$24.89M— | —— | —— | —— | ||
| -$80.19M+1.7% | -$75.81M+12.4% | -$72.35M+18.5% | -$77.68M+10.0% | -$81.54M+11.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CytomX Therapeutics generate?
- CytomX Therapeutics (CTMX) generated -$80.1M in operating cash flow over the trailing twelve months.
- What is CytomX Therapeutics's free cash flow?
- After $347.0K of capital expenditures, CytomX Therapeutics's free cash flow was -$80.2M over the trailing twelve months, up 1.7% year over year.
- Where does CytomX Therapeutics's cash flow data come from?
- Every line is extracted from CytomX Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
